The recent emergence of serum and glucocorticoid-regulated kinase (SGK3) as an oncogenic effector in PIK3CA-mutant breast cancer cells independent of AKT [140] has led to the examination of INPP4B as a mediator of PI3K/SGK3 signalling. This evidence concerns the gene PIK3CA and breast carcinoma.